United States set
language
Menu Shopping cart $0 Search

References to miR-1-3p

  • Tao, Ge, and James F. Martin. "Genetics: MicroRNAs get to the heart of development." Elife 2 (2013): e01710.
  • Zhao, Yong, Eva Samal, and Deepak Srivastava. "Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis." Nature 436.7048 (2005): 214-220.
  • Li, Jianzhe, et al. "MicroRNA-1 in cardiac diseases and cancers." The Korean Journal of Physiology & Pharmacology 18.5 (2014): 359-363.
  • Li, Qing, et al. "Attenuation of microRNA-1 derepresses the cytoskeleton regulatory protein twinfilin-1 to provoke cardiac hypertrophy." J Cell Sci 123.14 (2010): 2444-2452.
  • Ikeda, Sadakatsu, et al. "MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes." Molecular and cellular biology 29.8 (2009): 2193-2204.
  • Boštjančič, Emanuela, et al. "MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction." Cardiology 115.3 (2010): 163-169.
  • Girmatsion, Zenawit, et al. "Changes in microRNA-1 expression and I K1 up-regulation in human atrial fibrillation." Heart Rhythm6.12 (2009): 1802-1809.
  • D'alessandra, Yuri, et al. "Circulating microRNAs are new and sensitive biomarkers of myocardial infarction." European heart journal 31.22 (2010): 2765-2773.
  • Yan, Dongsheng, et al. "MicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma development." Journal of Biological Chemistry 284.43 (2009): 29596-29604.
  • Nasser, Mohd W., et al. "Down-regulation of micro-RNA-1 (miR-1) in lung cancer suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1." Journal of Biological Chemistry 283.48 (2008): 33394-33405.
  • Chiyomaru, Takeshi, et al. "Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer." Urologic Oncology: Seminars and Original Investigations. Vol. 30. No. 4. Elsevier, 2012.
  • Kojima, Satoko, et al. "Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer." British journal of cancer 106.2 (2012): 405-413.